CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
410.40
1.87%
Market Trading Hours* (UTC) Opens on Monday at 13:30

Mon - Thu: 13:30 - 20:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.46
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026179 %
Charges from full value of position ($-4.97)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026179%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.003957 %
Charges from full value of position ($0.75)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.003957%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Molina Healthcare Inc ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 418.2
Open* 410.85
1-Year Change* 52.68%
Day's Range* 407.61 - 412.42
52 wk Range 256.19-391.21
Average Volume (10 days) 308.23K
Average Volume (3 months) 7.68M
Market Cap 22.22B
P/E Ratio 23.75
Shares Outstanding 58.30M
Revenue 33.25B
EPS 16.05
Dividend (Yield %) N/A
Beta 0.45
Next Earnings Date Feb 7, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 28, 2024 410.40 -0.09 -0.02% 410.49 415.20 405.85
Mar 27, 2024 418.20 0.68 0.16% 417.52 423.01 416.10
Mar 26, 2024 418.21 8.81 2.15% 409.40 418.95 409.40
Mar 25, 2024 412.42 0.31 0.08% 412.11 414.47 407.95
Mar 22, 2024 414.56 -1.19 -0.29% 415.75 418.49 414.42
Mar 21, 2024 417.36 5.05 1.22% 412.31 419.76 410.61
Mar 20, 2024 415.64 1.35 0.33% 414.29 419.49 412.59
Mar 19, 2024 419.10 11.57 2.84% 407.53 419.45 407.53
Mar 18, 2024 410.13 10.16 2.54% 399.97 412.81 398.12
Mar 15, 2024 404.06 2.16 0.54% 401.90 407.20 400.36
Mar 14, 2024 406.65 3.66 0.91% 402.99 408.67 401.30
Mar 13, 2024 404.49 3.41 0.85% 401.08 409.57 400.06
Mar 12, 2024 402.41 4.05 1.02% 398.36 408.65 397.84
Mar 11, 2024 402.20 14.46 3.73% 387.74 403.56 387.74
Mar 8, 2024 392.55 5.05 1.30% 387.50 395.07 384.40
Mar 7, 2024 391.54 4.57 1.18% 386.97 392.92 386.83
Mar 6, 2024 388.34 4.39 1.14% 383.95 391.88 382.47
Mar 5, 2024 385.49 1.92 0.50% 383.57 386.51 381.43
Mar 4, 2024 386.46 3.18 0.83% 383.28 390.90 380.95
Mar 1, 2024 387.15 -3.77 -0.96% 390.92 390.94 380.35

Molina Healthcare Events

Time (UTC) Country Event
Wednesday, April 24, 2024

Time (UTC)

10:59

Country

US

Event

Q1 2024 Molina Healthcare Inc Earnings Release
Q1 2024 Molina Healthcare Inc Earnings Release

Forecast

-

Previous

-
Thursday, May 2, 2024

Time (UTC)

14:00

Country

US

Event

Molina Healthcare Inc Annual Shareholders Meeting
Molina Healthcare Inc Annual Shareholders Meeting

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 31974 27771 19423 16829 18890
Revenue 31974 27771 19423 16829 18890
Cost of Revenue, Total 27175 23704 15820 13905 15501
Gross Profit 4799 4067 3603 2924 3389
Total Operating Expense 30801 26776 18360 15770 17771
Selling/General/Admin. Expenses, Total 3184 2821 2390 1785 2098
Depreciation / Amortization 176 131 88 89 99
Operating Income 1173 995 1063 1059 1119
Interest Income (Expense), Net Non-Operating -110 -120 -102 -87 -115
Other, Net 0 -5
Net Income Before Taxes 1063 875 961 972 999
Net Income After Taxes 792 659 673 737 707
Net Income Before Extra. Items 792 659 673 737 707
Net Income 792 659 673 737 707
Income Available to Common Excl. Extra. Items 792 659 673 737 707
Income Available to Common Incl. Extra. Items 792 659 673 737 707
Diluted Net Income 792 659 673 737 707
Diluted Weighted Average Shares 58.5 58.6 60 64 67
Diluted EPS Excluding Extraordinary Items 13.5385 11.2457 11.2167 11.5156 10.5522
Diluted Normalized EPS 16.9263 12.788 11.9403 11.409 11.3233
Unusual Expense (Income) 266 120 62 -9 73
Total Extraordinary Items
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total revenue 8548 8327 8149 8223 7927
Revenue 8548 8327 8149 8223 7927
Cost of Revenue, Total 7306 7038 6871 6992 6748
Gross Profit 1242 1289 1278 1231 1179
Total Operating Expense 8189 7884 7694 8118 7592
Selling/General/Admin. Expenses, Total 784 787 763 856 783
Depreciation / Amortization 42 42 44 47 45
Unusual Expense (Income) 57 17 16 223 16
Operating Income 359 443 455 105 335
Interest Income (Expense), Net Non-Operating -27 -27 -28 -27 -28
Net Income Before Taxes 332 416 427 78 307
Net Income After Taxes 245 309 321 56 230
Net Income Before Extra. Items 245 309 321 56 230
Net Income 245 309 321 56 230
Income Available to Common Excl. Extra. Items 245 309 321 56 230
Income Available to Common Incl. Extra. Items 245 309 321 56 230
Dilution Adjustment
Diluted Net Income 245 309 321 56 230
Diluted Weighted Average Shares 58.1 57.9 58 58.5 58.3
Diluted EPS Excluding Extraordinary Items 4.21687 5.33679 5.53448 0.95726 3.94511
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 4.94085 5.55488 5.74186 3.69406 4.15072
Other, Net
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 10084 10064 7876 5967 6462
Cash and Short Term Investments 7505 7640 6029 4398 4507
Cash & Equivalents 4006 4438 4154 2452 2826
Short Term Investments 3499 3202 1875 1946 1681
Total Receivables, Net 2302 2177 1672 1406 1330
Accounts Receivable - Trade, Net 2302 2177 1672 1406 1330
Prepaid Expenses 277 247 175 134 149
Other Current Assets, Total 29 476
Total Assets 12314 12209 9532 6787 7154
Property/Plant/Equipment, Total - Net 302 524 462 450 241
Property/Plant/Equipment, Total - Gross 997 1156 1039 980 774
Accumulated Depreciation, Total -695 -632 -577 -530 -533
Goodwill, Net 1115 982 692 143
Intangibles, Net 275 270 249 29 190
Other Long Term Assets, Total 538 369 253 198 261
Total Current Liabilities 6855 7047 4965 3269 4246
Payable/Accrued 826 792 608 422 390
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 22 15 12 26 241
Other Current Liabilities, Total 5966 6205 4324 2796 3615
Total Liabilities 9350 9579 7436 4827 5507
Total Long Term Debt 2391 2392 2352 1468 1217
Long Term Debt 2176 2173 2127 1237 1020
Capital Lease Obligations 215 219 225 231 197
Deferred Income Tax
Other Liabilities, Total 104 140 119 90 44
Total Equity 2964 2630 2096 1960 1647
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.058 0.058 0.059 0.062 0
Additional Paid-In Capital 328 236 199 175 643
Retained Earnings (Accumulated Deficit) 2796 2399 1860 1781 1012
Other Equity, Total -160.058 -5.058 36.941 3.938 -8
Total Liabilities & Shareholders’ Equity 12314 12209 9532 6787 7154
Total Common Shares Outstanding 58 58 59 62 62
Accrued Expenses 41 35 21 25
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 12468 11441 11159 10084 10492
Cash and Short Term Investments 9676 8796 8364 7505 7881
Cash & Equivalents 5565 4910 4554 4006 4242
Short Term Investments 4111 3886 3810 3499 3639
Total Receivables, Net 2460 2385 2536 2302 2220
Accounts Receivable - Trade, Net 2460 2385 2536 2302 2220
Prepaid Expenses 332 260 259 277 391
Total Assets 14870 13661 13371 12314 12793
Property/Plant/Equipment, Total - Net 290 285 274 259 412
Intangibles, Net 1471 1348 1369 1390 1263
Other Long Term Assets, Total 641 587 569 581 626
Total Current Liabilities 8492 7537 7614 6855 7242
Payable/Accrued 1090 857 787 889 818
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 7402 6680 6827 5966 6424
Total Liabilities 10991 10040 10083 9350 9752
Total Long Term Debt 2378 2381 2381 2391 2392
Long Term Debt 2179 2178 2177 2176 2175
Capital Lease Obligations 199 203 204 215 217
Other Liabilities, Total 121 122 88 104 118
Total Equity 3879 3621 3288 2964 3041
Preferred Stock - Non Redeemable, Net 0 0 0 0 0
Common Stock 0.058 0.058 0.058 0.058 0.058
Additional Paid-In Capital 373 341 296 328 289
Retained Earnings (Accumulated Deficit) 3671 3426 3117 2796 2937
Other Equity, Total -165.058 -146.058 -125.058 -160.058 -185.058
Total Liabilities & Shareholders’ Equity 14870 13661 13371 12314 12793
Total Common Shares Outstanding 58 58 58 58 58
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 792 659 673 737 707
Cash From Operating Activities 773 2119 1898 434 -314
Cash From Operating Activities 176 131 88 89 127
Deferred Taxes -66 -24 -19 10 -6
Non-Cash Items 319 130 84 24 107
Cash Taxes Paid 340 235 321 239 240
Cash Interest Paid 108 127 112 78 93
Changes in Working Capital -448 1223 1072 -426 -1249
Cash From Investing Activities -790 -1653 -400 -293 1143
Capital Expenditures -91 -77 -74 -57 -30
Other Investing Cash Flow Items, Total -699 -1576 -326 -236 1173
Cash From Financing Activities -441 -183 217 -559 -1193
Financing Cash Flow Items 13 -19 2 29 18
Issuance (Retirement) of Stock, Net -454 -181 -644 -568 -549
Issuance (Retirement) of Debt, Net 0 17 859 -20 -662
Net Change in Cash -458 283 1715 -418 -364
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line 321 792 736 506 258
Cash From Operating Activities 916 773 985 731 363
Cash From Operating Activities 44 176 129 84 40
Deferred Taxes 1 -66 -35 3 16
Non-Cash Items 30 319 77 51 26
Changes in Working Capital 520 -448 78 87 23
Cash From Investing Activities -302 -790 -938 -591 74
Capital Expenditures -32 -91 -81 -50 -23
Other Investing Cash Flow Items, Total -270 -699 -857 -541 97
Cash From Financing Activities -65 -441 -258 -268 -77
Financing Cash Flow Items -7 13 -5 -15 -25
Issuance (Retirement) of Stock, Net -58 -454 -253 -253 -52
Issuance (Retirement) of Debt, Net 0
Net Change in Cash 549 -458 -211 -128 360

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Molina Healthcare Company profile

About Molina Healthcare, Inc.

Molina Healthcare, Inc. is a provider of managed healthcare services under the Medicaid and Medicare programs, and through the state insurance marketplaces. The Company operates through four segments: Medicaid, Medicare, Marketplace, and Other. The Medicaid, Medicare, and Marketplace segments represent the government-funded or sponsored programs under which the Company offers managed healthcare services. Medicaid provides healthcare and long-term care services and support to low-income Americans. Medicare is a federal program that provides eligible persons age 65 and over and some disabled persons with a variety of hospital, medical insurance, and prescription drug benefits. Marketplace insurance exchanges allows individuals and small groups to purchase federally subsidized health insurance. The Company arranges healthcare services for its members through contracts with a network of providers, including independent physicians and physician groups, hospitals, and ancillary providers.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Molina Healthcare, Inc. revenues increased 43% to $27.77B. Net income decreased 2% to $659M. Revenues reflect Medicaid segment increase of 40% to $21.23B. Net income was offset by General and administrative expenses - Ba increase of 39% to $1.96B (expense). Basic Earnings per Share excluding Extraordinary Items decreased from $11.41 to $11.40.

Equity composition

Common Stock $.000666667 Par, 05/11, 80M auth., 45,855,577 o/s.Insiders and strategic owns 35.42%. IPO: 7/02/03, 6.6M shares @ $17.50 by Banc of AmericaSecurities LLC. 05/11, 3-for-2 stock split.

Industry: Managed Healthcare (NEC)

200 Oceangate, Suite 100
LONG BEACH
CALIFORNIA 90802
US

Income Statement

  • Annual
  • Quarterly

News

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

Four reasons why Bitcoin is surging to record highs

Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.

10:18, 14 March 2024

China’s National People’s Congress: The markets have again been left wanting more

China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.

08:23, 8 March 2024
Facade on the Federal Reserve Building in Washington DC

Central Banks: which one will cut first?

Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut

13:14, 6 March 2024

Nvidia (NVDA) confronts high expectations for Q4 results

Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.

12:13, 20 February 2024

People also watch

ETH/USD

3,556.84 Price
-0.610% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

US100

18,249.40 Price
-0.200% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 7.0

BTC/USD

70,610.80 Price
-0.700% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

XRP/USD

0.64 Price
-0.020% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.01168

Still looking for a broker you can trust?

Join the 580.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading